MedGene Therapeutics, Inc. — Form D
MedGene Therapeutics, Inc. of SILVER SPRING, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-29. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-29
- Form: D
- Accession: 0001789652-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $1.1M
- Investors: 2
- Date of first sale: 2021-06-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-404510
Issuer
- Name: MedGene Therapeutics, Inc.
- CIK: 0001789652
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2015
- Address: 11800 GEORGIA AVENUE, SILVER SPRING, MD, 20902
- Phone: (301) 500-6746
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Tae-erk Kim | Director | Silver Spring, MD |
| Yonghan Park | Director | Silver Spring, MD |
| James Song | Director | Silver Spring, MD |
| Yonghan Park | Executive Officer | Silver Spring, MD |
| Sean McCrohon | Executive Officer | Silver Spring, MD |
Other filings by this issuer (1)
More